SCHEMBL2269588

SCHEMBL2269588

FC(F)(F)c1ccc(Cl)c(OBOc2cc(C(F)(F)F)ccc2Cl)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 1/20 0.43
HTR2A P28223 5/20 0.41
SLC6A4 P31645 5/20 0.41
KCNH2 Q12809 5/20 0.41
SCD O00767 4/20 0.39
KMT2A Q03164 2/20 0.38
MRGPRX4 Q96LA9 2/20 0.38
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
TSHR P16473 1/20 0.37
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ALK Q9UM73 1/20 0.37
MAPT P10636 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
MCL1 Q07820 1/20 0.36
PPARA Q07869 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1274838 0.85 PDE2A (0.47) PDE2AKMT2AMRGPRX4MEN1
SCHEMBL13347572 0.78 MAPT (0.50) PDE2AHTR2ASLC6A4KCNH2KMT2A
SCHEMBL10933173 0.78 NOTUM (0.43) PDE2AHTR2ASLC6A4KCNH2SCD
SCHEMBL531610 0.76 L3MBTL1 (0.45) HTR2AKMT2AMEN1ALDH1A1L3MBTL1
SCHEMBL8194032 0.76 L3MBTL1 (0.45) HTR2ASLC6A4KMT2AMEN1ALDH1A1
SCHEMBL22954131 0.76 HTR2A (0.43) PDE2AHTR2ASLC6A4KCNH2SCD
SCHEMBL6584574 0.75 ALDH1A1 (0.43) HTR2ASLC6A4KCNH2KMT2AMRGPRX4
SCHEMBL521919 0.74 RXRA (0.44) PDE2AHTR2ASLC6A4KCNH2ALDH1A1
SCHEMBL16991134 0.74 IDO1 (0.43) PDE2AMRGPRX4ALDH1A1ATML3MBTL1
SCHEMBL14237634 0.74 GPR3 (0.41) KCNH2MRGPRX4L3MBTL1MAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2536710-B1 PIPERIDINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2016-07-13 EP disclosed
US-8486967-B2 Heteroaryl substituted piperidines HOFFMANN-LA ROCHE INC. (US) 2013-07-16 US disclosed
EP-2536710-A2 PIPERIDINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2012-12-26 EP disclosed
WO-2011101304-A2 PIPERIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2011-08-25 WO disclosed
US-20110201605-A1 HETEROARYL SUBSTITUTED PIPERIDINES HOFFMANN-LA ROCHE, INC. 2011-08-18 US disclosed
US-7589095-B2 4-phenyl-pyrimidine-2-carbonitrile derivatives N.V. ORGANON (NL) 2009-09-15 US disclosed
EP-1758870-B1 4-PHENYL-PYRIMIDINE-2-CARBONITRILE DERIVATIVES ORGANON NV (NL) 2008-08-13 EP disclosed
US-20080090813-A1 4-Phenyl-Pyrimidine-2-Carbonitrile Derivatives Cai, Jiaqiang 2008-04-17 US disclosed
EP-1758870-A1 4-PHENYL-PYRIMIDINE-2-CARBONITRILE DERIVATIVES N.V. Organon (NL) 2007-03-07 EP disclosed
WO-2005121106-A1 4-PHENYL-PYRIMIDINE-2-CARBONITRILE DERIVATIVES N.V. ORGANON (NL) 2005-12-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110201605-A1 HETEROARYL SUBSTITUTED PIPERIDINES APP, HPGDS, PSEN1 PDE2A 469/4885HTR2A 5/4885SLC6A4 1549/4885
US-20080090813-A1 4-Phenyl-Pyrimidine-2-Carbonitrile Derivatives P2RY4, P2RX4, P2RY1 PDE2A 1289/4885HTR2A 3130/4885SLC6A4 1719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.